Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-15-009818

Chief Technology Officer sold 50,000 shares at an average $8.90 ($444,800)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kidron Miriam Chief Technology Officer 2015-12-28 Sale −11,000 $9.27 $101,915 181,450 D
Kidron Miriam Chief Technology Officer 2015-12-29 Sale −15,000 $9.08 $136,178 166,450 D
Kidron Miriam Chief Technology Officer 2015-12-30 Sale −24,000 $8.61 $206,707 142,450 D
Open-market sales · 50,000 sh · avg $8.90 · $444,800
Loading xslF345X03/f4122815kidron_oramedpharma.xml…